{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:59:49Z","timestamp":1788620389883,"version":"build-2803163510"},"reference-count":23,"publisher":"Japan Atherosclerosis Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2026,4,1]]},"DOI":"10.5551\/jat.65947","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T22:07:34Z","timestamp":1764281254000},"page":"449-469","source":"Crossref","is-referenced-by-count":3,"title":["Long-term Safety and Efficacy of Bempedoic Acid in Japanese Patients with Hypercholesterolemia: the CLEAR-J LONG"],"prefix":"10.5551","volume":"33","author":[{"given":"Daisaku","family":"Masuda","sequence":"first","affiliation":[{"name":"Department of Cardiology, Rinku General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouji","family":"Kajinami","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kanazawa Medical University"},{"name":"Current affiliation: Department of Sport and Medical Science, Teikyo University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Sakayoshi","sequence":"additional","affiliation":[{"name":"Headquarters of Clinical Development, Otsuka Pharmaceutical Co. Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Yokota","sequence":"additional","affiliation":[{"name":"Headquarters of Clinical Development, Otsuka Pharmaceutical Co. Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Nagamine","sequence":"additional","affiliation":[{"name":"Medical Affairs, Otsuka Pharmaceutical Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Morikawa-Isogai","sequence":"additional","affiliation":[{"name":"Medical Affairs, Otsuka Pharmaceutical Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuya","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rinku General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, Brauer M, Kutty VR, Gupta R, Wielgosz A, AlHabib KF, Dans A, Lopez-Jaramillo P, Avezum A, Lanas F, Oguz A, Kruger IM, Diaz R, Yusoff. K, Mony P, Chifamba J, Yeates K, Kelishadi R, Yusufali A, Khatib R, Rahman O, Zatonska K, Iqbal R, Wei L, Bo H, Rosengren A, Kaur M, Mohan V, Lear SA, Teo KK, Leong D, O\u2019Donnell M, McKee M, Dagenais G: Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet, 2020; 395: 795-808","DOI":"10.1016\/S0140-6736(19)32008-2"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Silverman MG, Ference BA, Im K, Wiviott SD, Giugliano RP, Grundy SM, Braunwald E, Sabatine MS: Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis. JAMA, 2016; 316: 1289-1297","DOI":"10.1001\/jama.2016.13985"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Wang N, Fulcher J, Abeysuriya N, Park L, Kumar S, Di Tanna GL, Wilcox I, Keech A, Rodgers A, Lal S: Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants. Lancet Diabetes Endocrinol, 2020; 8: 36-49","DOI":"10.1016\/S2213-8587(19)30388-2"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Imamura T, Doi Y, Arima H, Yonemoto K, Hata J, Kubo M, Tanizaki Y, Ibayashi S, Iida M, Kiyohara Y: LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population: the Hisayama study. Stroke, 2009; 382: 382-388","DOI":"10.1161\/STROKEAHA.108.529537"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Okamura T, Tsukamoto K, Arai H, Fujioka Y, Ishigaki Y, Koba S, Ohmura H, Shoji T, Yokote K, Yoshida H, Yoshida M, Deguchi J, Dobashi K, Fujiyoshi A, Hamaguchi H, Hara M, Harada-Shiba M, Hirata T, Iida M, Ikeda Y, Ishibashi S, Kanda H, Kihara S, Kitagawa K, Kodama S, Koseki M, Maezawa Y, Masuda D, Miida T, Miyamoto Y, Nishimura R, Node K, Noguchi M, Ohishi M, Saito I, Sawada S, Sone H, Takemoto M, Wakatsuki A, Yanai H: Japan Atherosclerosis Society (JAS) Guidelines for prevention of atherosclerotic cardiovascular diseases 2022. J Atheroscler Thromb, 2024; 31: 641-853","DOI":"10.5551\/jat.GL2022"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Mitani H, Suzuki K, Ako J, Iekushi K, Majewska R, Touzeni S, Yamashita S: Achievement rates for low-density lipoprotein cholesterol goals in patients at high risk of atherosclerotic cardiovascular disease in a real-world setting in Japan. J Atheroscler Thromb, 2023; 30: 1622-1634","DOI":"10.5551\/jat.63940"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Tsushima Y, Hatipoglu B: Statin intolerance: a review and update. Endocr Pract, 2023; 29: 566-571","DOI":"10.1016\/j.eprac.2023.03.004"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Pinkosky SL, Newton RS, Day EA, Ford RJ, Lhotak S, Austin RC, Birch CM, Smith BK, Filippov S, Groot PHE, Steinberg GR, Lalwani ND: Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis. Nat Commun, 2016; 7: 13457","DOI":"10.1038\/ncomms13457"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Nissen SE, Lincoff AM, Brennan D, Ray KK, Mason D, Kastelein JJP, Thompson PD, Libby P, Cho L, Plutzky J, Bays HE, Moriarty PM, Menon V, Grobbee DE, Louie MJ, Chen C-F, Li N, Bloedon L, Robinson P, Horner M, Sasiela WJ, McCluskey J, Davey D, Fajardo-Campos P, Petrovic P, Fedacko J, Zmuda W, Lukyanov Y, Nichollset SJ: Bempedoic acid and cardiovascular outcomes in statin-intolerant patients. N Engl J Med, 2023; 388: 1353-1364","DOI":"10.1056\/NEJMoa2215024"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Yamashita S, Fujita H, Yokota D, Morikawa-Isogai Y, Kitamoto R: Efficacy and safety of bempedoic acid for hypercholesterolemia in Japan: a phase 2 multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-finding trial. J Atheroscler Thromb, 2025; 32: 1053-1070","DOI":"10.5551\/jat.65336"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Yamashita S, Kiyosue A, Fujita H, Yokota D, Nakamura Y, Yasuda S: Efficacy and safety of bempedoic acid in Japanese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled phase 3 study (the CLEAR-J trial). Circ J, 2025; 89: 1256-1265","DOI":"10.1253\/circj.CJ-25-0089"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Ray KK, Bays HE, Catapano AL, Lalwani ND, Bloedon LT, Sterling LR, Robinson PL, Ballantyne CM: CLEAR Harmony trial: safety and efficacy of bempedoic acid to reduce LDL cholesterol. N Engl J Med, 2019; 380: 1022-1032","DOI":"10.1056\/NEJMoa1803917"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Amore BM, MacDougall DE, Hanselman JC, Emery MG: Phase 1, Single- and multiple-ascending-dose, food-effect, and east asian subject studies to assess the pharmacokinetics, safety, and tolerability of bempedoic acid, a selective inhibitor of adenosine triphosphate citrate lyase. Clin Pharmacol Drug Dev, 2023; 12: 1022-1035","DOI":"10.1002\/cpdd.1297"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, Umemoto S, Egusa G, Ohmura H, Okamura T, Kihara S, Koba S, Saito I, Shoji T, Daida H, Tsukamoto K, Deguchi J, Dohi S, Dobashi K, Hamaguchi H, Hara M, Hiro T, Biro S, Fujioka Y, Maruyama C, Miyamoto Y, Murakami Y, Yokode M, Yoshida H, Rakugi H, Wakatsuki A, Yamashita S, Committee for Epidemiology and Clinical Management of Atherosclerosis: Japan Atherosclerosis Society (JAS) Guidelines for prevention of atherosclerotic cardiovascular diseases 2017. J Atheroscler Thromb, 2018; 25: 846-984","DOI":"10.5551\/jat.GL2017"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Goldberg AC, Leiter LA, Stroes ESG, Baum SJ, Hanselman JC, Bloedon LT, Lalwani ND, Patel PM, Zhao X, Duell PB: Effect of bempedoic acid vs placebo added to maximally tolerated statins on low-density lipoprotein cholesterol in patients at high risk for cardiovascular disease: the CLEAR Wisdom randomized clinical trial. JAMA, 2019; 322: 1780-1788","DOI":"10.1001\/jama.2019.16585"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Ballantyne CM, Bays H, Catapano AL, Goldberg A, Ray KK, Saseen JJ: Role of bempedoic acid in clinical practice. Cardiovasc Drugs Ther, 2021; 35: 853-864","DOI":"10.1007\/s10557-021-07147-5"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Bays HE, Banach M, Catapano AL, Duell PB, Gotto AM Jr., Laufs U, Leiter LA, Mancini GBJ, Ray KK, LeAnne T. Bloedon LE, Sasiela WJ, Ye Z, Ballantyne CM: Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials. Clin Lipidol, 2020; 14: 649-659","DOI":"10.1016\/j.jacl.2020.08.009"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Averna M, Bilato C, Sesti G; Italian Clinical Network on Bempedoic Acid: Clinical evaluation of bempedoic acid for the treatment of hyperlipidaemia. Nutr Metab Cardiovasc Dis, 2022; 32: 17-20","DOI":"10.1016\/j.numecd.2021.09.023"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Laufs U, Ballantyne CM, Banach M, Bays H, Catapano AL, Duell PB, Goldberg AC, Gotto AM, Leiter LA, Ray KK, Bloedon LAT, MacDougall D, Zhang Y, Mancini GBJ: Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials. J Clin Lipidol, 2022; 16: 286-297","DOI":"10.1016\/j.jacl.2022.03.001"},{"key":"20","unstructured":"20) Cholesterol Treatment Trialists\u2019 Collaboration: Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials. Lancet, 2022; 400: 832-845"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Ference BA, Ray KK, Catapano AL, Ference TB, Burgess S, Neff DR, Oliver-Williams C, Wood AM, Butterworth AS, Angelantonio ED, Danesh J, Kastelein JJP, Nicholls SJ: Mendelian Randomization study of ACLY and cardiovascular disease. N Engl J Med, 2019; 380: 1033-1042","DOI":"10.1056\/NEJMoa1806747"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Ridker PM: Clinician\u2019s guide to reducing inflammation to reduce atherothrombotic risk: JACC review topic of the week. J Am Coll Cardiol, 2018; 72: 3320-3331","DOI":"10.1016\/j.jacc.2018.06.082"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Arima H, Kubo M, Yonemoto K, Doi Y, Ninomiya T, Tanizaki Y, Hata J, Matsumura K, Iida M, Kiyohara Y: High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study. Arterioscler Thromb Vasc Biol, 2008; 28: 1385-1391","DOI":"10.1161\/ATVBAHA.107.157164"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/4\/33_65947\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:25:22Z","timestamp":1775276722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/4\/33_65947\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.65947","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"65947"}}